1: Mosa FES, Alqahtani MA, El-Ghiaty MA, Barakat K, El-Kadi AOS. Identifying novel aryl hydrocarbon receptor (AhR) modulators from clinically approved drugs: In silico screening and In vitro validation. Arch Biochem Biophys. 2024 Apr;754:109958. doi: 10.1016/j.abb.2024.109958. Epub 2024 Mar 16. PMID: 38499054.
2: Wu X, Wang N, Liang J, Wang B, Jin Y, Liu B, Yang Y. Is the Triggering of PD-L1 Dimerization a Potential Mechanism for Food-Derived Small Molecules in Cancer Immunotherapy? A Study by Molecular Dynamics. Int J Mol Sci. 2023 Jan 11;24(2):1413. doi: 10.3390/ijms24021413. PMID: 36674929; PMCID: PMC9864258.
3: Courault P, Demarquay G, Zimmer L, Lancelot S. Cluster headache: state of the art of pharmacological treatments and therapeutic perspectives. Fundam Clin Pharmacol. 2021 Jun;35(3):595-619. doi: 10.1111/fcp.12636. Epub 2020 Dec 24. PMID: 33290608.
4: Lee MT, Goodstein MB, Lalic G. Synthesis of Isomerically Pure (Z)-Alkenes from Terminal Alkynes and Terminal Alkenes: Silver-Catalyzed Hydroalkylation of Alkynes. J Am Chem Soc. 2019 Oct 30;141(43):17086-17091. doi: 10.1021/jacs.9b09336. Epub 2019 Oct 21. PMID: 31633923; PMCID: PMC7304281.
5: Rodriguez-Merchan EC. Topical therapies for knee osteoarthritis. Postgrad Med. 2018 Sep;130(7):607-612. doi: 10.1080/00325481.2018.1505182. Epub 2018 Aug 29. PMID: 30156934.
6: Sałat K, Jakubowska A, Kulig K. Zucapsaicin for the treatment of neuropathic pain. Expert Opin Investig Drugs. 2014 Oct;23(10):1433-40. doi: 10.1517/13543784.2014.956079. Epub 2014 Aug 29. PMID: 25171227.
7: Schnitzer TJ, Pelletier JP, Haselwood DM, Ellison WT, Ervin JE, Gordon RD, Lisse JR, Archambault WT, Sampson AR, Fezatte HB, Phillips SB, Bernstein JE. Civamide cream 0.075% in patients with osteoarthritis of the knee: a 12-week randomized controlled clinical trial with a longterm extension. J Rheumatol. 2012 Mar;39(3):610-20. doi: 10.3899/jrheum.110192. Epub 2011 Nov 15. PMID: 22089461.
8: Bayes M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2006 Jul-Aug;28(6):379-412. PMID: 16894408.
9: Rapoport AM, Bigal ME, Tepper SJ, Sheftell FD. Intranasal medications for the treatment of migraine and cluster headache. CNS Drugs. 2004;18(10):671-85. doi: 10.2165/00023210-200418100-00004. PMID: 15270595.
10: Markley HG. Topical agents in the treatment of cluster headache. Curr Pain Headache Rep. 2003 Apr;7(2):139-43. doi: 10.1007/s11916-003-0024-2. PMID: 12628056.
11: Saper JR, Klapper J, Mathew NT, Rapoport A, Phillips SB, Bernstein JE. Intranasal civamide for the treatment of episodic cluster headaches. Arch Neurol. 2002 Jun;59(6):990-4. doi: 10.1001/archneur.59.6.990. PMID: 12056936.
12: Diamond S, Freitag F, Phillips SB, Bernstein JE, Saper JR. Intranasal civamide for the acute treatment of migraine headache. Cephalalgia. 2000 Jul;20(6):597-602. doi: 10.1046/j.1468-2982.2000.00088.x. PMID: 11075845.
13: Bourne N, Bernstein DI, Stanberry LR. Civamide (cis-capsaicin) for treatment of primary or recurrent experimental genital herpes. Antimicrob Agents Chemother. 1999 Nov;43(11):2685-8. doi: 10.1128/AAC.43.11.2685. PMID: 10543747; PMCID: PMC89543.
14: Arnar DO, Cai JJ, Lee HC, Martins JB. Electrophysiologic effects of civamide (zucapsaicin) on canine cardiac tissue in vivo and in vitro. J Cardiovasc Pharmacol. 1998 Dec;32(6):875-83. doi: 10.1097/00005344-199812000-00003. PMID: 9869492.
15: Lu J, Cwik M. Determination of capsaicin and zucapsaicin in human serum by high-performance liquid chromatography with fluorescence detection. J Chromatogr B Biomed Sci Appl. 1997 Nov 7;701(1):135-9. doi: 10.1016/s0378-4347(97)00347-2. PMID: 9389349.